Efficacy of topical calcineurin inhibitors in vitiligo
Author:
Affiliation:
1. Faculty of Medicine and Dentistry; Canada
2. Division of Dermatology and Cutaneous Sciences; Department of Medicine; University of Alberta; Edmonton; Alberta; Canada
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-4632.2012.05697.x/fullpdf
Reference50 articles.
1. Innovative use of topical calcineurin inhibitors;Lin;Dermatol Clin,2010
2. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study;Kawalek;Dermatol Surg,2004
3. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study;Nordal;J Eur Acad Dermatol Venereol,2011
4. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo;Mehrabi;Arch Dermatol,2006
5. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo;Lepe;Arch Dermatol,2003
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non‐segmental vitiligo;Journal of Cosmetic Dermatology;2024-02-13
2. Multiple gene-drug prediction tool reveals Rosiglitazone based treatment pathway for non-segmental vitiligo;Inflammation;2023-12-30
3. Efficacy and safety of natural Aloe Vera gel in the treatment of stable vitiligo;Clinical Epidemiology and Global Health;2023-07
4. Autoimmunity in vitiligo: Therapeutic implications and opportunities;Autoimmunity Reviews;2022-01
5. Comparative efficacy between localized 308‐nm excimer light and targeted 311‐nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single‐blind comparison study;Photodermatology, Photoimmunology & Photomedicine;2020-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3